12/23
04:05 pm
cbll
Ceribell to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Low
Report
Ceribell to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
12/9
12:54 pm
cbll
CeriBell (NASDAQ: CBLL) had its price target raised by analysts at TD Cowen from $31.00 to $36.00. They now have a "buy" rating on the stock.
Low
Report
CeriBell (NASDAQ: CBLL) had its price target raised by analysts at TD Cowen from $31.00 to $36.00. They now have a "buy" rating on the stock.
12/9
11:49 am
cbll
CeriBell (NASDAQ: CBLL) had its price target raised by analysts at Canaccord Genuity Group Inc. from $31.00 to $33.00. They now have a "buy" rating on the stock.
Low
Report
CeriBell (NASDAQ: CBLL) had its price target raised by analysts at Canaccord Genuity Group Inc. from $31.00 to $33.00. They now have a "buy" rating on the stock.
11/13
09:10 am
cbll
CeriBell (NASDAQ: CBLL) had its price target raised by analysts at Canaccord Genuity Group Inc. from $30.00 to $31.00. They now have a "buy" rating on the stock.
Low
Report
CeriBell (NASDAQ: CBLL) had its price target raised by analysts at Canaccord Genuity Group Inc. from $30.00 to $31.00. They now have a "buy" rating on the stock.
11/12
04:05 pm
cbll
Ceribell Reports Third Quarter 2024 Financial Results
Medium
Report
Ceribell Reports Third Quarter 2024 Financial Results
11/11
08:00 am
cbll
Ceribell Receives Authority to Operate from the U.S. Department of Veterans Affairs
Low
Report
Ceribell Receives Authority to Operate from the U.S. Department of Veterans Affairs
11/7
04:05 pm
cbll
Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Low
Report
Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
11/5
08:17 am
cbll
CeriBell (NASDAQ: CBLL) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $30.00 price target on the stock.
Low
Report
CeriBell (NASDAQ: CBLL) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $30.00 price target on the stock.
11/5
07:33 am
cbll
CeriBell (NASDAQ: CBLL) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $30.00 price target on the stock.
Low
Report
CeriBell (NASDAQ: CBLL) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $30.00 price target on the stock.
11/5
07:33 am
cbll
CeriBell (NASDAQ: CBLL) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $32.00 price target on the stock.
Low
Report
CeriBell (NASDAQ: CBLL) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $32.00 price target on the stock.
11/5
07:33 am
cbll
CeriBell (NASDAQ: CBLL) is now covered by analysts at TD Cowen. They set a "buy" rating and a $31.00 price target on the stock.
Low
Report
CeriBell (NASDAQ: CBLL) is now covered by analysts at TD Cowen. They set a "buy" rating and a $31.00 price target on the stock.
11/5
07:33 am
cbll
CeriBell (NASDAQ: CBLL) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $32.00 price target on the stock.
Low
Report
CeriBell (NASDAQ: CBLL) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $32.00 price target on the stock.
11/5
07:30 am
cbll
CeriBell (NASDAQ: CBLL) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
Low
Report
CeriBell (NASDAQ: CBLL) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
10/29
04:05 pm
cbll
Ceribell to Report Third Quarter 2024 Financial Results on November 12, 2024
Low
Report
Ceribell to Report Third Quarter 2024 Financial Results on November 12, 2024
10/16
04:05 pm
cbll
New Clinical Evidence Links Ceribell Point-of-Care EEG to Shorter Hospital Stays and Better Functional Outcomes Compared to Conventional EEG
Low
Report
New Clinical Evidence Links Ceribell Point-of-Care EEG to Shorter Hospital Stays and Better Functional Outcomes Compared to Conventional EEG
10/15
05:00 pm
cbll
CeriBell, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
Medium
Report
CeriBell, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
10/10
11:27 pm
cbll
CeriBell, Inc. Announces Pricing of Upsized Initial Public Offering
Medium
Report
CeriBell, Inc. Announces Pricing of Upsized Initial Public Offering